Phase
Condition
Atrial Fibrillation
Chest Pain
Arrhythmia
Treatment
N/AClinical Study ID
Ages 18-90 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
We plan to retrospectively collect data from five atrial fibrillation treatment centers, including The Fourth Affiliated Hospital of Zhejiang University School of Medicine, Taizhou Hospital of Zhejiang Province, The Affiliated Hospital of Yunnan University, Jinhua People's Hospital, and Beilun District People's Hospital, for patients diagnosed with atrial fibrillation who underwent their first catheter ablation between January 2016 and December 2023.
Exclusion
Exclusion Criteria:
Patients undergoing repeated AF ablation procedures;
AF patients with incomplete follow-up data;
AF patients lacking preoperative laboratory tests or key textual modality results (echocardiography, ambulatory ECG);
Patients with comorbid conditions including acute myocardial infarction, valvularheart disease, malignant tumors, or hyperthyroidism, and those with AF recurrencewithin 3 months post-ablation.
Study Design
Study Description
Connect with a study center
The Affiliated Hospital of Yunnan University
Kunming, Yunnan 650000
ChinaActive - Recruiting
Jinhua People's Hospital
Jinhua, Zhejiang 321000
ChinaActive - Recruiting
Beilun District People's Hospital
Ningbo, Zhejiang 315800
ChinaActive - Recruiting
Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University
Taizhou, Zhejiang 317000
ChinaActive - Recruiting
The Fourth Affiliated Hospital of Zhejiang University School of Medicine
Yiwu, Zhejiang 322000
ChinaActive - Recruiting
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.